Insider · CIK 0001939444
Kevin C Karrels
Files at HTLF (HEARTLAND FINANCIAL USA INC). First filing Jan 2, 2024, latest Jan 2, 2024.
In brief
Kevin C Karrels files SEC Form 4 as officer at HTLF (HEARTLAND FINANCIAL USA INC). Since Jan 2, 2024, Kevin C Karrels has reported 1 open-market buy worth $3,208 and 0 open-market sells worth $0, the latest filed on Jan 2, 2024.
A track record needs three past buys with six months of prices behind them; Kevin C Karrels has 0, so none is measured yet.
The newest scored trade: bought $3,208 of HTLF on Dec 31, 2023, filed Jan 2, 2024, scored 15 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | HTLFbuy HEARTLAND FINANCIAL USA INC | $3,208 93 shares | +3% | - |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 31, 2023 | HTLF HEARTLAND FINANCIAL USA INC | POpen-market purchase Common Stock | +93 | $34.49 | $3,208 | 3,418 | Jan 2, 2024 |
Questions about Kevin C Karrels
Answered from the filings on this page, as of the latest one.
Is Kevin C Karrels buying or selling?
Not in the last 12 months. Kevin C Karrels's latest open-market trade on SEC Form 4 was bought $3,208 of HTLF on Dec 31, 2023.
How did Kevin C Karrels's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kevin C Karrels has 0.
Where does Kevin C Karrels file Form 4?
Kevin C Karrels has filed Form 4 at HTLF (HEARTLAND FINANCIAL USA INC) as EVP, Head of Consumer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.